Home

Omnicell, Inc. - Common Stock (OMCL)

44.99
-0.32 (-0.71%)

Omnicell Inc is a healthcare technology company that specializes in streamlining medication management and supply chain solutions for pharmacies and healthcare facilities

The company develops automated systems and software that enhance the efficiency of medication dispensing, inventory management, and patient safety. By offering a comprehensive suite of products, including automated dispensing cabinets, central pharmacy automation, and cloud-based analytics, Omnicell aims to improve the operational workflows of healthcare providers, reduce medication errors, and ultimately enhance patient care. Their innovative solutions are designed to meet the evolving needs of the healthcare industry, supporting successful medication therapies and optimizing pharmacy operations.

SummaryNewsPress ReleasesChartHistoricalFAQ
Beyond The Numbers: 6 Analysts Discuss Omnicell Stockbenzinga.com
Via Benzinga · November 21, 2024
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?benzinga.com
Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).
Via Benzinga · November 3, 2024
What 5 Analyst Ratings Have To Say About Omnicellbenzinga.com
Via Benzinga · October 31, 2024
Omnicell Catapults And Breaks Out After Obliterating Profit Expectationsinvestors.com
The company makes software the manages medication dispensing.
Via Investor's Business Daily · October 30, 2024
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecastbenzinga.com
Via Benzinga · October 30, 2024
The Analyst Verdict: Omnicell In The Eyes Of 6 Expertsbenzinga.com
Via Benzinga · October 9, 2024
The Analyst Landscape: 5 Takes On Omnicellbenzinga.com
Via Benzinga · August 23, 2024
Earnings Scheduled For February 8, 2024benzinga.com
Companies Reporting Before The Bell • Ares Management (NYSEARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via Benzinga · February 8, 2024
Piper Sandler Upgrades Omnicell: Here's What You Need To Knowbenzinga.com
Via Benzinga · November 3, 2023
S&P 500 Edges Lower; US Crude Oil Inventories Fallbenzinga.com
Via Benzinga · October 30, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · October 30, 2024
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
Via Benzinga · October 30, 2024
Crude Oil Moves Lower; Moderna Shares Plungebenzinga.com
Via Benzinga · August 1, 2024
Analyst Expectations for Omnicell's Futurebenzinga.com
Via Benzinga · October 3, 2023
Dow Drops Over 500 Points As Data Rolls Intalkmarkets.com
Stocks are paring this morning's gains that followed Meta Platforms' upbeat quarterly results.
Via Talk Markets · August 1, 2024
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In Julybenzinga.com
Via Benzinga · August 1, 2024
Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · August 1, 2024
3 Russell 2000 Stocks to Buy at a 52-week Low in Julyinvestorplace.com
The Russell 2000 is trailing the Nasdaq Composite and S&P500, yet there are still plenty of Russel stocks worth looking into.
Via InvestorPlace · July 24, 2024
OMCL Stock Earnings: Omnicell Beats EPS, Beats Revenue for Q1 2024investorplace.com
OMCL stock results show that Omnicell beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 2, 2024
3 Robotics Stocks That Could Soar as the Technology Advancesinvestorplace.com
Discover three robotics stocks set for significant growth as technology evolves. Don't miss out on these opportunities.
Via InvestorPlace · March 19, 2024
The MACD Indicator: Making Technical Analysis Workinvestorplace.com
We examine how ordinary investors can use some of Wall Street's best tools like the MACD indicator to beat them at their own game.
Via InvestorPlace · December 7, 2023
The Relative Strength Index (RSI) Indicator: Does It Work?investorplace.com
The Relative Strength Index (RSI) is a contrarian technical analysis indicator that uses prices to find "overbought" and "oversold" assets.
Via InvestorPlace · November 17, 2023
Airbnb, Blackstone Rise On News They'll Join S&P 500 Indexinvestors.com
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.
Via Investor's Business Daily · September 2, 2023
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Gainers OmniLit Acquisition Corp. (NASDAQOLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via Benzinga · November 2, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023benzinga.com
Via Benzinga · October 11, 2023